Department of Ophthalmology, Klinikum Ludwigshafen, Ludwigshafen, Germany.
Invest Ophthalmol Vis Sci. 2012 Jan 3;53(1):42-6. doi: 10.1167/iovs.11-8486.
Recent studies suggest that the cannulation of retinal vessels may provide a potential access route for the administration of thrombolytic agents in retinal vessel occlusion. However, the major problem with available techniques is the limited visualization of retinal vessels with conventional surgical microscopes, making it difficult to effectively control the targeted injection of drugs.
The authors developed a novel single-piece catheter system for the endoscopically guided puncture of microvessels. Experimental punctures of retinal vessels with injection of fluid were performed in porcine cadaver eyes using a standard high-resolution gradient index microendoscope introduced through the pars plana.
Endoscopically guided punctures were successfully performed in porcine branch retinal veins at various distances from the optic disc. Injection of recombinant tissue plasminogen activator (rt-PA), hypertonic solution (hyper HES), or normal saline solution into the vessel lumen was accomplished under direct endoscopic view in a safe and reliable manner.
Endoscopically guided puncture of retinal microvessels is feasible and can be performed through a pars plana entry without additional micromanipulation devices. This novel technique may be a safe and effective approach to catheter-directed endovascular thrombolysis in retinal vascular occlusive diseases.
最近的研究表明,视网膜血管插管可能为视网膜血管阻塞中溶栓剂的给药提供潜在的进入途径。然而,现有技术的主要问题是常规手术显微镜对视网膜血管的可视化有限,使得难以有效地控制靶向药物注射。
作者开发了一种用于内窥镜引导的微血管穿刺的新型单件导管系统。使用标准的高分辨率梯度指数微内窥镜通过扁平部引入,在猪尸体眼球中进行了视网膜血管的实验性穿刺和注射。
在距视盘不同距离的猪分支视网膜静脉中成功进行了内窥镜引导的穿刺。在直接内窥镜观察下,以安全可靠的方式将重组组织纤溶酶原激活剂(rt-PA)、高渗溶液(hyper HES)或生理盐水溶液注入血管腔。
内窥镜引导的视网膜微血管穿刺是可行的,可以通过扁平部进入而无需额外的微操作装置来完成。这种新的技术可能是治疗视网膜血管阻塞性疾病的导管导向血管内溶栓的一种安全有效的方法。